Mrozik H - Search Results

1

Synthesis and biological activity of 13-epi-avermectins: potent anthelmintic agents with an increased margin of safety.

Blizzard TA, Margiatto GM, Mrozik H, Shoop WL, Frankshun RA, Fisher MH. Blizzard TA, et al. Among authors: mrozik h. J Med Chem. 1992 Oct 16;35(21):3873-8. doi: 10.1021/jm00099a014. J Med Chem. 1992. PMID: 1433196

2

Syntheses and biological activities of 13-substituted avermectin aglycons.

Mrozik H, Linn BO, Eskola P, Lusi A, Matzuk A, Preiser FA, Ostlind DA, Schaeffer JM, Fisher MH. Mrozik H, et al. J Med Chem. 1989 Feb;32(2):375-81. doi: 10.1021/jm00122a015. J Med Chem. 1989. PMID: 2913297

3

Structure and activity of avermectins and milbemycins in animal health.

Shoop WL, Mrozik H, Fisher MH. Shoop WL, et al. Among authors: mrozik h. Vet Parasitol. 1995 Sep;59(2):139-56. doi: 10.1016/0304-4017(94)00743-v. Vet Parasitol. 1995. PMID: 7483237 Review.

4

Efficacy in sheep and pharmacokinetics in cattle that led to the selection of eprinomectin as a topical endectocide for cattle.

Shoop WL, DeMontigny P, Fink DW, Williams JB, Egerton JR, Mrozik H, Fisher MH, Skelly BJ, Turner MJ. Shoop WL, et al. Among authors: mrozik h. Int J Parasitol. 1996 Nov;26(11):1227-35. doi: 10.1016/s0020-7519(96)00122-1. Int J Parasitol. 1996. PMID: 9024866

5

Synthesis of gem-difluoro-avermectin derivatives: potent anthelmintic and anticonvulsant agents.

Meinke PT, Shoop WL, Michael BF, Blizzard TA, Dawson GR, Fisher MH, Mrozik H. Meinke PT, et al. Among authors: mrozik h. Bioorg Med Chem Lett. 1998 Dec 15;8(24):3643-6. doi: 10.1016/s0960-894x(98)00674-x. Bioorg Med Chem Lett. 1998. PMID: 9934486

6

Affinity probes for the avermectin binding proteins.

Meinke PT, Rohrer SP, Hayes EC, Schaeffer JM, Fisher MH, Mrozik H. Meinke PT, et al. Among authors: mrozik h. J Med Chem. 1992 Oct 16;35(21):3879-84. doi: 10.1021/jm00099a015. J Med Chem. 1992. PMID: 1433197

7

The chemistry and pharmacology of avermectins.

Fisher MH, Mrozik H. Fisher MH, et al. Among authors: mrozik h. Annu Rev Pharmacol Toxicol. 1992;32:537-53. doi: 10.1146/annurev.pa.32.040192.002541. Annu Rev Pharmacol Toxicol. 1992. PMID: 1605577 Review. No abstract available.

8

Avermectins and milbemycins against Fasciola hepatica: in vivo drug efficacy and in vitro receptor binding.

Shoop WL, Ostlind DA, Rohrer SP, Mickle G, Haines HW, Michael BF, Mrozik H, Fisher MH. Shoop WL, et al. Among authors: mrozik h. Int J Parasitol. 1995 Aug;25(8):923-7. doi: 10.1016/0020-7519(95)00026-x. Int J Parasitol. 1995. PMID: 8550292

9

Ivermectin, a new broad-spectrum antiparasitic agent.

Chabala JC, Mrozik H, Tolman RL, Eskola P, Lusi A, Peterson LH, Woods MF, Fisher MH, Campbell WC, Egerton JR, Ostlind DA. Chabala JC, et al. Among authors: mrozik h. J Med Chem. 1980 Oct;23(10):1134-6. doi: 10.1021/jm00184a014. J Med Chem. 1980. PMID: 6893469

10

Avermectin acyl derivatives with anthelmintic activity.

Mrozik H, Eskola P, Fisher MH, Egerton JR, Cifelli S, Ostlind DA. Mrozik H, et al. J Med Chem. 1982 Jun;25(6):658-63. doi: 10.1021/jm00348a010. J Med Chem. 1982. PMID: 7097720

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters